Alzamend Neuro, Inc. (ALZN)
2.03
-0.04
(-2.09%)
USD |
NASDAQ |
Dec 24, 12:59
2.03
0.00 (0.00%)
After-Hours: 13:59
Alzamend Neuro Market Cap: 6.374M for Dec. 24, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Medpace Holdings, Inc. | 16.10B |
| Embecta Corp. | 706.83M |
| BrightSpring Health Services, Inc. | 6.808B |
| CEL-SCI Corp. | 14.23M |
| AIM ImmunoTech, Inc. | 0.9782M |
Market Cap Related Metrics
| Price to Book Value | 1.457 |
| Price | 2.03 |
| Earnings Yield | -270.7% |